Skip to main content
International Journal of Oncology logoLink to International Journal of Oncology
. 2021 Nov 1;59(6):100. doi: 10.3892/ijo.2021.5280

miR-222 regulates sorafenib resistance and enhance tumorigenicity in hepatocellular carcinoma

Kai Liu, Songyang Liu, Wei Zhang, Bai Ji, Yingchao Wang, Yahui Liu
PMCID: PMC8577794  PMID: 34726253

Int J Oncol 45: 1537-1546, 2014; DOI: 10.3892/ijo.2014.2577

Following the publication of this paper, it was drawn to the Editors' attention by a concerned reader that the flow cytometric data in Fig. 3A and western blotting data featured in Figs. 3C and 7 were strikingly similar to data appearing in different form in other articles that shared some of the same authors. Owing to the fact that the contentious data in the above article were already under consideration for publication, or had already been published, elsewhere prior to its submission to International Journal of Oncology, the Editor has decided that this paper should be retracted from the Journal. After having been in contact with the authors, they agreed with the decision to retract the paper. The Editor apologizes to the readership for any inconvenience caused.


Articles from International Journal of Oncology are provided here courtesy of Spandidos Publications

RESOURCES